Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2012, Article ID 983814, 18 pages
http://dx.doi.org/10.1155/2012/983814
Review Article

Ectopic Fat and Insulin Resistance: Pathophysiology and Effect of Diet and Lifestyle Interventions

1Departments of Endocrinology & Metabolism and General Internal Medicine, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
2Walaeus Library, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
3Department of Radiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands

Received 15 July 2011; Revised 16 January 2012; Accepted 17 January 2012

Academic Editor: Andreas Höflich

Copyright © 2012 M. Snel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Obesity and overweight,” WHO Report No.: fact sheet no 311, 2012, http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
  2. F. X. Pi-Sunyer, “Medical hazards of obesity,” Annals of Internal Medicine, vol. 119, no. 7, pp. 655–660, 1993. View at Google Scholar · View at Scopus
  3. S. Z. Yanovski, “Overweight, obesity, and health risk: National Task Force on the Prevention and Treatment of Obesity,” Archives of Internal Medicine, vol. 160, no. 7, pp. 898–904, 2000. View at Google Scholar · View at Scopus
  4. A. E. Field, E. H. Coakley, A. Must et al., “Impact of overweight on the risk of developing common chronic diseases during a 10-year period,” Archives of Internal Medicine, vol. 161, no. 13, pp. 1581–1586, 2001. View at Google Scholar · View at Scopus
  5. W. C. Willett, W. H. Dietz, and G. A. Colditz, “Guidelines for healthy weight,” New England Journal of Medicine, vol. 341, no. 6, pp. 427–434, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Chan, E. B. Rimm, G. A. Colditz, M. J. Stampfer, and W. C. Willett, “Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men,” Diabetes Care, vol. 17, no. 9, pp. 961–969, 1994. View at Google Scholar · View at Scopus
  7. G. A. Colditz, W. C. Willett, A. Rotnitzky, and J. E. Manson, “Weight gain as a risk factor for clinical diabetes mellitus in women,” Annals of Internal Medicine, vol. 122, no. 7, pp. 481–486, 1995. View at Google Scholar · View at Scopus
  8. R. P. Wildman, P. Muntner, K. Reynolds et al., “The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004),” Archives of Internal Medicine, vol. 168, no. 15, pp. 1617–1624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. I. M. Jazet, H. Pijl, and A. E. Meinders, “Adipose tissue as an endocrine organ: impact on insulin resistance,” Netherlands Journal of Medicine, vol. 61, no. 6, pp. 194–212, 2003. View at Google Scholar · View at Scopus
  10. M. Blüher, “Adipose tissue dysfunction in obesity,” Experimental and Clinical Endocrinology and Diabetes, vol. 117, no. 6, pp. 241–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. D. H. Van Raalte, N. J. Van Der Zijl, and M. Diamant, “Pancreatic steatosis in humans: cause or marker of lipotoxicity?” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 4, pp. 478–485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. N. J. Van Der Zijl, G. H. Goossens, C. C. M. Moors et al., “Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 2, pp. 459–467, 2011. View at Publisher · View at Google Scholar
  13. E. L. Lim, K. G. Hollingsworth, B. S. Aribisala, M. J. Chen, J. C. Mathers, and R. Taylor, “Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol,” Diabetologia, vol. 54, no. 10, pp. 2506–2514, 2011. View at Publisher · View at Google Scholar
  14. M. Jernås, J. Palming, K. Sjöholm et al., “Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression,” The FASEB Journal, vol. 20, no. 9, pp. 1540–1542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. U. Özcan, Q. Cao, E. Yilmaz et al., “Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes,” Science, vol. 306, no. 5695, pp. 457–461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. F. Gregor and G. S. Hotamisligil, “Adipocyte stress: the endoplasmic reticulum and metabolic disease,” Journal of Lipid Research, vol. 48, no. 9, pp. 1905–1914, 2007. View at Publisher · View at Google Scholar
  17. J. F. C. Glatz, A. Bonen, and J. J. F. P. Luiken, “Exercise and insulin increase muscle fatty acid uptake by recruiting putative fatty acid transporters to the sarcolemma,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 5, no. 4, pp. 365–370, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Morino, K. F. Petersen, and G. I. Shulman, “Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction,” Diabetes, vol. 55, no. 2, pp. S9–S15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Szendroedi and M. Roden, “Ectopic lipids and organ function,” Current Opinion in Lipidology, vol. 20, no. 1, pp. 50–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. V. T. Samuel, Z. X. Liu, X. Qu et al., “Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease,” Journal of Biological Chemistry, vol. 279, no. 31, pp. 32345–32353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Krssak, K. Falk Petersen, A. Dresner et al., “Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study,” Diabetologia, vol. 42, no. 1, pp. 113–116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Perseghin, P. Scifo, F. De Cobelli et al., “Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents,” Diabetes, vol. 48, no. 8, pp. 1600–1606, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. Pan, S. Lillioja, A. D. Kriketos et al., “Skeletal muscle triglyceride levels are inversely related to insulin action,” Diabetes, vol. 46, no. 6, pp. 983–988, 1997. View at Google Scholar · View at Scopus
  24. S. Jacob, J. Machann, K. Rett et al., “Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects,” Diabetes, vol. 48, no. 5, pp. 1113–1119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. D. I. W. Phillips, S. Caddy, V. Ilic et al., “Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects,” Metabolism, vol. 45, no. 8, pp. 947–950, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. B. H. Goodpaster, J. He, S. Watkins, and D. E. Kelley, “Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5755–5761, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. L. J. C. Van Loon and B. H. Goodpaster, “Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state,” Pflugers Archiv European Journal of Physiology, vol. 451, no. 5, pp. 606–616, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. E. Kelley, B. Goodpaster, R. R. Wing, and J. A. Simoneau, “Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss,” American Journal of Physiology, vol. 277, no. 6, pp. E1130–E1141, 1999. View at Google Scholar · View at Scopus
  29. J. A. Simoneau and D. E. Kelley, “Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM,” Journal of Applied Physiology, vol. 83, no. 1, pp. 166–171, 1997. View at Google Scholar · View at Scopus
  30. J. A. Simoneau, J. H. Veerkamp, L. P. Turcotte, and D. E. Kelley, “Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss,” FASEB Journal, vol. 13, no. 14, pp. 2051–2060, 1999. View at Google Scholar · View at Scopus
  31. K. F. Petersen, S. Dufour, D. Befroy, R. Garcia, and G. I. Shulman, “Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes,” New England Journal of Medicine, vol. 350, no. 7, pp. 664–671, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Morino, K. F. Petersen, S. Dufour et al., “Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents,” Journal of Clinical Investigation, vol. 115, no. 12, pp. 3587–3593, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. K. F. Petersen, S. Dufour, and G. I. Shulman, “Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents,” PLoS Medicine, vol. 2, no. 9, article e233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. D. E. Kelley, J. He, E. V. Menshikova, and V. B. Ritov, “Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes,” Diabetes, vol. 51, no. 10, pp. 2944–2950, 2002. View at Google Scholar · View at Scopus
  35. J. Szendroedi, A. I. Schmid, M. Chmelik et al., “Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes,” PLoS Medicine, vol. 4, no. 5, article e154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Phielix, V. B. Schrauwen-Hinderling, M. Mensink et al., “Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients,” Diabetes, vol. 57, no. 11, pp. 2943–2949, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. V. B. Schrauwen-Hinderling, M. E. Kooi, M. K. C. Hesselink et al., “Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects,” Diabetologia, vol. 50, no. 1, pp. 113–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Schrauwen, V. Schrauwen-Hinderling, J. Hoeks, and M. K. C. Hesselink, “Mitochondrial dysfunction and lipotoxicity,” Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 266–271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. V. Greco, G. Mingrone, A. Giancaterini et al., “Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion,” Diabetes, vol. 51, no. 1, pp. 144–151, 2002. View at Google Scholar · View at Scopus
  40. P. Malenfant, D. R. Joanisse, R. Thériault, B. H. Goodpaster, D. E. Kelley, and J.-A. Simoneau, “Fat content in individual muscle fibers of lean and obese subjects,” International Journal of Obesity, vol. 25, no. 9, pp. 1316–1321, 2001. View at Publisher · View at Google Scholar
  41. K. F. Petersen, S. Dufour, D. Befroy, M. Lehrke, R. E. Hendler, and G. I. Shulman, “Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes,” Diabetes, vol. 54, no. 3, pp. 603–608, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Sato, Y. Tamura, H. Watada et al., “Brief report: effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 8, pp. 3326–3329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Tamura, Y. Tanaka, F. Sato et al., “Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3191–3196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Mingrone, G. Rosa, P. Di Rocco et al., “Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-α reduction and GLUT4 expression enhancement,” International Journal of Obesity, vol. 26, no. 9, pp. 1165–1172, 2002. View at Publisher · View at Google Scholar
  45. D. E. Larson-Meyer, L. K. Heilbronn, L. M. Redman et al., “Effect of calorie restriction with or without exercise on insulin sensitivity, β-cell function, fat cell size, and ectopic lipid in overweight subjects,” Diabetes Care, vol. 29, no. 6, pp. 1337–1344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Malenfant, A. Tremblay, E. Doucet, P. Imbeault, J.-A. Simoneau, and D. R. Joanisse, “Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training,” American Journal of Physiology, vol. 280, no. 4 43-4, pp. E632–E639, 2001. View at Google Scholar
  47. J. J. Dubé, F. Amati, F. G. S. Toledo et al., “Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide,” Diabetologia, vol. 54, no. 5, pp. 1147–1156, 2011. View at Publisher · View at Google Scholar
  48. S. B. Haugaard, A. Vaag, C. E. Høy, and S. Madsbad, “Desaturation of skeletal muscle structural and depot lipids in obese individuals during a very-low-calorie diet intervention,” Obesity, vol. 15, no. 1, pp. 117–125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Lara-Castro, B. R. Newcomer, J. Rowell et al., “Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects,” Metabolism: Clinical and Experimental, vol. 57, no. 1, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. I. M. Jazet, G. Schaart, A. Gastaldelli et al., “Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients,” Diabetologia, vol. 51, no. 2, pp. 309–319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. F. G. S. Toledo, E. V. Menshikova, K. Azuma et al., “Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content,” Diabetes, vol. 57, no. 4, pp. 987–994, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. F. G. S. Toledo, E. V. Menshikova, V. B. Ritov et al., “Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes,” Diabetes, vol. 56, no. 8, pp. 2142–2147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. J. He, B. H. Goodpaster, and D. E. Kelley, “Effects of weight loss and physical activity on muscle lipid content and droplet size,” Obesity Research, vol. 12, no. 5, pp. 761–769, 2004. View at Google Scholar · View at Scopus
  54. T. P. J. Solomon, S. N. Sistrun, R. K. Krishnan et al., “Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults,” Journal of Applied Physiology, vol. 104, no. 5, pp. 1313–1319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. J. J. Dubé, F. Amati, M. Stefanovic-Racic, F. G. S. Toledo, S. E. Sauers, and B. H. Goodpaster, “Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited,” American Journal of Physiology, vol. 294, no. 5, pp. E882–E888, 2008. View at Publisher · View at Google Scholar
  56. R. C. R. Meex, V. B. Schrauwen-Hinderling, E. Moonen-Kornips et al., “Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity,” Diabetes, vol. 59, no. 3, pp. 572–579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Lazo and J. M. Clark, “The epidemiology of nonalcoholic fatty liver disease: a global perspective,” Seminars in Liver Disease, vol. 28, no. 4, pp. 339–350, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Andersen and C. Gluud, “Liver morphology in morbid obesity: a literature study,” International Journal of Obesity, vol. 8, no. 2, pp. 97–106, 1984. View at Google Scholar · View at Scopus
  59. S. Bellentani, G. Saccoccio, F. Masutti et al., “Prevalence of and risk factors for hepatic steatosis in northern Italy,” Annals of Internal Medicine, vol. 132, no. 2, pp. 112–117, 2000. View at Google Scholar · View at Scopus
  60. E. Fabbrini, S. Sullivan, and S. Klein, “Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications,” Hepatology, vol. 51, no. 2, pp. 679–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. L. S. Szczepaniak, P. Nurenberg, D. Leonard et al., “Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population,” American Journal of Physiology, vol. 288, no. 2, pp. E462–E468, 2005. View at Publisher · View at Google Scholar
  62. K. F. Petersen, S. Dufour, J. Feng et al., “Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18273–18277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. D. E. Kleiner, E. M. Brunt, M. Van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. K. M. Korenblat, E. Fabbrini, B. S. Mohammed, and S. Klein, “Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects,” Gastroenterology, vol. 134, no. 5, pp. 1369–1375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Bugianesi, A. Gastaldelli, E. Vanni et al., “Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms,” Diabetologia, vol. 48, no. 4, pp. 634–642, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. A. J. Sanyal, C. Campbell-Sargent, F. Mirshahi et al., “Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities,” Gastroenterology, vol. 120, no. 5, pp. 1183–1192, 2001. View at Google Scholar · View at Scopus
  67. A. Seppälä-Lindroos, S. Vehkavaara, A.-M. Häkkinen et al., “Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 7, pp. 3023–3028, 2002. View at Publisher · View at Google Scholar
  68. A. Gastaldelli, M. Kozakova, K. Höjlund et al., “Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population,” Hepatology, vol. 49, no. 5, pp. 1537–1544, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. S. L. Colles, J. B. Dixon, P. Marks, B. J. Strauss, and P. E. O'Brien, “Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging,” American Journal of Clinical Nutrition, vol. 84, no. 2, pp. 304–311, 2006. View at Google Scholar · View at Scopus
  70. C. Thamer, J. Machann, N. Stefan et al., “High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention,” Obesity, vol. 15, no. 2, pp. 531–538, 2007. View at Publisher · View at Google Scholar
  71. E. L. Thomas, A. E. Brynes, G. Hamilton et al., “Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 12, no. 36, pp. 5813–5819, 2006. View at Google Scholar · View at Scopus
  72. M. Tiikkainen, R. Bergholm, S. Vehkavaara et al., “Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content,” Diabetes, vol. 52, no. 3, pp. 701–707, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. A. P. M. Viljanen, P. Iozzo, R. Borra et al., “Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 50–55, 2009. View at Publisher · View at Google Scholar
  74. M. A. Huang, J. K. Greenson, C. Chao et al., “One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: a pilot study,” American Journal of Gastroenterology, vol. 100, no. 5, pp. 1072–1081, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. T. Ueno, H. Sugawara, K. Sujaku et al., “Therapeutic effects of restricted diet and exercise in obese patients with fatty liver,” Journal of Hepatology, vol. 27, no. 1, pp. 103–107, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Andersen, C. Gluud, M. B. Franzmann, and P. Christoffersen, “Hepatic effects of dietary weight loss in morbidly obese subjects,” Journal of Hepatology, vol. 12, no. 2, pp. 224–229, 1991. View at Google Scholar · View at Scopus
  77. N. A. Spassiani and J. L. Kuk, “Exercise and the fatty liver,” Applied Physiology, Nutrition and Metabolism, vol. 33, no. 4, pp. 802–807, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Magkos, “Exercise and fat accumulation in the human liver,” Current Opinion in Lipidology, vol. 21, no. 6, pp. 507–517, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Shah, A. Stufflebam, T. N. Hilton, D. R. Sinacore, S. Klein, and D. T. Villareal, “Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults,” Obesity, vol. 17, no. 12, pp. 2162–2168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Shojaee-Moradie, K. C. Baynes, C. Pentecost et al., “Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism,” Diabetologia, vol. 50, no. 2, pp. 404–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. N. A. Johnson, T. Sachinwalla, D. W. Walton et al., “Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss,” Hepatology, vol. 50, no. 4, pp. 1105–1112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. C. A. Slentz, L. A. Bateman, L. H. Willis et al., “Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT,” American Journal of Physiology, vol. 301, no. 5, pp. E1033–E1039, 2011. View at Publisher · View at Google Scholar
  83. H. S. Sacks and J. N. Fain, “Human epicardial adipose tissue: a review,” American Heart Journal, vol. 153, no. 6, pp. 907–917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. S. W. Rabkin, “Epicardial fat:properties, function and relationship to obesity,” Obesity Reviews, vol. 8, no. 3, pp. 253–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. J. M. Marchington, C. A. Mattacks, and C. M. Pond, “Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties,” Comparative Biochemistry and Physiology B, vol. 94, no. 2, pp. 225–232, 1989. View at Google Scholar · View at Scopus
  86. J. M. Marchington and C. M. Pond, “Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro,” International Journal of Obesity, vol. 14, no. 12, pp. 1013–1022, 1990. View at Google Scholar · View at Scopus
  87. T. Mazurek, L. Zhang, A. Zalewski et al., “Human epicardial adipose tissue is a source of inflammatory mediators,” Circulation, vol. 108, no. 20, pp. 2460–2466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. A. R. Baker, A. L. Harte, N. Howell et al., “Epicardial adipose tissue as a source of nuclear factor-κB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 261–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. S. G. Ahn, H. S. Lim, D. Y. Joe et al., “Relationship of epicardial adipose tissue by echocardiography to coronary artery disease,” Heart, vol. 94, no. 3, article e7, 2008. View at Google Scholar · View at Scopus
  90. M. Greif, A. Becker, F. Von Ziegler et al., “Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 5, pp. 781–786, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. J. W. Jeong, H. J. Myung, H. Y. Kyeong et al., “Echocardiographic epicardial fat thickness and coronary artery disease,” Circulation Journal, vol. 71, no. 4, pp. 536–539, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. G. A. Rosito, J. M. Massaro, U. Hoffmann et al., “Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample the framingham heart study,” Circulation, vol. 117, no. 5, pp. 605–613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. G. Iacobellis and F. Leonetti, “Epicardial adipose tissue and insulin resistance in obese subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 6300–6302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. C. P. Wang, H. L. Hsu, W. C. Hung et al., “Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis,” Clinical Endocrinology, vol. 70, no. 6, pp. 876–882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. T. D. Wang, W. J. Lee, F. Y. Shih et al., “Relations of epicardial adipose tissue measured by multidetector computed tomography to components of the metabolic syndrome are region-specific and independent of anthropometric indexes and intraabdominal visceral fat,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 662–669, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. M. K. Kim, K. Tanaka, M. J. Kim et al., “Comparison of epicardial, abdominal and regional fat compartments in response to weight loss,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 11, pp. 760–766, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Iacobellis, N. Singh, S. Wharton, and A. M. Sharma, “Substantial changes in epicardial fat thickness after weight loss in severely obese subjects,” Obesity, vol. 16, no. 7, pp. 1693–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Snel, J. T. Jonker, S. Hammer et al. et al., “Long-Term Beneficial Effect of a 16-Week Very Low Calorie Diet on Pericardial Fat in Obese Type 2 Diabetes Mellitus Patients,” Obesity. In press. View at Publisher · View at Google Scholar
  99. M. K. Kim, T. Tomita, M. J. Kim, H. Sasai, S. Maeda, and K. Tanaka, “Aerobic exercise training reduces epicardial fat in obese men,” Journal of Applied Physiology, vol. 106, no. 1, pp. 5–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. T. E. Brinkley, J. Ding, J. J. Carr, and B. J. Nicklas, “Pericardial fat loss in postmenopausal women under conditions of equal energy deficit,” Medicine & Science in Sports & Exercise, vol. 43, no. 5, pp. 808–814, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. R. W. Van Der Meer, J. Doornbos, S. Kozerke et al., “Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers,” Radiology, vol. 245, no. 1, pp. 251–257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. P. Iozzo, R. Lautamaki, R. Borra et al., “Contribution of glucose tolerance and gender to cardiac adiposity,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 11, pp. 4472–4482, 2009. View at Publisher · View at Google Scholar
  103. J. M. McGavock, I. Lingvay, I. Zib et al., “Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study,” Circulation, vol. 116, no. 10, pp. 1170–1175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. L. J. Rijzewijk, R. W. van der Meer, J. W. A. Smit et al., “Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus,” Journal of the American College of Cardiology, vol. 52, no. 22, pp. 1793–1799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. T. Zhou, P. Grayburn, A. Karim et al., “Lipotoxic heart disease in obese rats: implications for human obesity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1784–1789, 2000. View at Publisher · View at Google Scholar · View at Scopus
  106. C. Christoffersen, E. Bollano, M. L. S. Lindegaard et al., “Cardiac lipid accumulation associated with diastolic dysfunction in obese mice,” Endocrinology, vol. 144, no. 8, pp. 3483–3490, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. L. R. Peterson, P. Herrero, K. B. Schechtman et al., “Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women,” Circulation, vol. 109, no. 18, pp. 2191–2196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. L. J. Rijzewijk, R. W. van der Meer, H. J. Lamb et al., “Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging,” Journal of the American College of Cardiology, vol. 54, no. 16, pp. 1524–1532, 2009. View at Google Scholar · View at Scopus
  109. S. Hammer, R. W. Van Der Meer, H. J. Lamb et al., “Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus,” American Journal of Physiology, vol. 295, no. 3, pp. E714–E718, 2008. View at Publisher · View at Google Scholar
  110. S. Hammer, R. W. Van Der Meer, H. J. Lamb et al., “Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 2, pp. 497–503, 2008. View at Publisher · View at Google Scholar
  111. A. P.M. Viljanen, A. Karmi, R. Borra et al., “Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults,” American Journal of Cardiology, vol. 103, no. 12, pp. 1721–1726, 2009. View at Publisher · View at Google Scholar
  112. S. Hammer, M. Snel, H. J. Lamb et al., “Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function,” Journal of the American College of Cardiology, vol. 52, no. 12, pp. 1006–1012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. V. B. Schrauwen-Hinderling, M. K. C. Hesselink, R. Meex et al., “Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 4, pp. 1932–1938, 2010. View at Publisher · View at Google Scholar
  114. V. B. Schrauwen-Hinderling, R. C. R. Meex, M. K. C. Hesselink et al., “Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction,” Cardiovascular Diabetology, vol. 10, article 47, 2011. View at Publisher · View at Google Scholar
  115. J. Vague, “La differenciation sexuelle: facteur determinant des formes: de l'obesite,” La Presse Médicale, vol. 55, pp. 339–340, 1947. View at Google Scholar
  116. E. Ravussin and S. R. Smith, “Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus,” Annals of the New York Academy of Sciences, vol. 967, pp. 363–378, 2002. View at Google Scholar · View at Scopus
  117. R. W. Van Der Meer, S. Hammer, H. J. Lamb et al., “Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 7, pp. 2702–2708, 2008. View at Publisher · View at Google Scholar
  118. P. D. Cani and N. M. Delzenne, “The role of the gut microbiota in energy metabolism and metabolic disease,” Current Pharmaceutical Design, vol. 15, no. 13, pp. 1546–1558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Diamant, E. E. Blaak, and W. M. de Vos, “Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?” Obesity Reviews, vol. 12, no. 4, pp. 272–281, 2011. View at Publisher · View at Google Scholar
  120. M. Daniel, K. G. Rowley, R. Mcdermott, A. Mylvaganam, and K. O'Dea, “Diabetes incidence in an Australian aboriginal population: an 8-year follow-up study,” Diabetes Care, vol. 22, no. 12, pp. 1993–1998, 1999. View at Google Scholar · View at Scopus